Skip to main navigation menu Skip to main content Skip to site footer

Special Edition Submission: "3D Printing for Medicine: biomaterials, processes and techniques"

Vol. 2 No. 1 (2019): March-September

The Brazilian sectoral innovation system in the field of Tissue Engineering and Bioprinting: actors, challenges and perspectives



The objective of this work is to map the main actors within the Brazilian innovation system framework in the field of tissue engineering and bioprinting, and analyze the main conditioners related to entrepreneurship and innovation. While keeping as a backdrop, the history of 3D Biotechnology Solutions startup, its challenges and projects. Tissue engineering is a subcategory of regenerative medicine with the purpose of repairing or substituting, partially or completely, tissues or organs that have been affected by some disease or lesion. The conventional methods used for the production of these biomaterials via tissue engineering do not have the capacity to mimic the reality of native structures in the nano, micro and macro scales, while guaranteeing the reproducibility andscalability ofthematerials. Technologies such as 3D bioprinting or additive manufacturing could change the way that many diseases are treated in the medium term by replacing the damaged tissues with custom bio-similar constructs. Mapping and reflections based on the innovation systems framework contribute to organize stimulus policies, stimulate interaction between actors, identify gaps and technological demands and periodically organize the analysis and expansion of this system in Brazil.


  1. - Langer, R. (1993). VacantiJP. Tissue engineering. Science, 260(5110), 920-926.
  2. - Rider, P., Kačarević, Ž. P., Alkildani, S., Retnasingh, S., & Barbeck, M. (2018). Bioprinting of tissue engineering scaffolds. Journal of Tissue Engineering.
  3. - Russell, W. M. S., Burch, R. L., & Hume, C. W. (1959). The principles of humane experimental technique (Vol. 238). London: Methuen.
  4. - Choudhury, D., Anand, S., & Naing, M. W. (2018). The arrival of commercial bioprinters–Towards 3D bioprinting revolution. Int J Bioprint, 4(2), 139.
  5. - Bergin, J. 2016: Bioprinting: Technologies and Global markets, BCC Research, USA.
  6. - 3D Bioprinitng Market Size, share and trends analysis report by technology (Magnetic levitation , inkjet based, syringe based, laser based), by application , and segment forecast, 2018-2024, 2018. Available from:
  7. - Li, P. H. (2014). 3D bioprinting technologies: patents, innovation and access. Law, Innovation and Technology, 6(2), 282-304.
  8. - Freeman, C. Technology policy and economic performance: lessons from Japan. London: Frances Pinter, 1987.
  9. - Lundvall, B. Å. (Ed.). (2010). National systems of innovation: Toward a theory of innovation and interactive learning (Vol. 2). Anthem press.
  10. - Richard R. Nelson and Sidney G. Winter. 1982. An Evolutionary Theory of Economic Change. Cambridge, Massachusetts: The Belknap Press of Harvard University Press.
  11. - Malerba, F. (2002). Sectoral systems of innovation and production. Research policy, 31(2), 247-264.
  12. - Chaminade, C., & Esquist, C. (2010). Rationales for public policy intervention in the innovation process: Systems of innovation approach. Chapters.
  13. - Jacobsson, S., & Bergek, A. (2004). Transforming the energy sector: the evolution of technological systems in renewable energy technology. Industrial and corporate change, 13(5), 815-849.
  14. - Go, A. S., Mozaffarian, D., Roger, V. r. L., Benjamin, E. J., Berry, J. D., Borden, W. B. et al. (2013). Heart Disease and Stroke StatisticsGÇö2013 Update: A Report From the American Heart Association. Circulation, 127, e6-e245.
  15. - Hobson, R. W., Mackey, W. C., Ascher, E., Murad, M. H., Calligaro, K. D., Comerota, A. J. et al. (2008). Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter, 48, 480-486.
  16. - Nomi, M., Atala, A., De Coppi, P., Soker, S., 2002. Principals of neovascularization for tissue engineering. Mol. Aspects Med. 23, 463–483.
  17. - Hashi, C. K., Derugin, N., Janairo, R. R., Lee, R., Schultz, D., Lotz, J. et al. (2010). Antithrombogenic Modification of Small-Diameter Microfibrous Vascular Grafts. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 1621-1627.
  18. - Carrabba M and Madeddu P (2018) Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts. Front. Bioeng. Biotechnol. 6:41.
  19. - Antonios, V. S., Noel, A. A., Steckelberg, J. M., Wilson, W. R., Mandrekar, J. N., Harmsen, W. S. et al. (2006). Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect., 53, 49-55.
  20. - Kannan RY, Salacinski HJ, Sales K, Butler P, Seifalian AM (2005) The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 26: 1857-1875.
  21. - Kakisis, J. D., Liapis, C. D., Breuer, C., & Sumpio, B. E. (2005). Artificial blood vessel: the Holy Grail of peripheral vascular surgery. Journal of vascular surgery, 41(2), 349-354.
  22. - Meinhart J, Deutsch M, Zilla, P. 1997. Eight years of clinical endothelial cell transplantation. Closing the gap between prosthetic grafts and vein grafts. ASAIO J 43:M515–521.
  23. - Isenberg, B. C., Williams, C., & Tranquillo, R. T. (2006). Small-Diameter Artificial Arteries Engineered In Vitro. Circulation Research, 98, 25-35.
  24. - Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U.J. Gene transfer strategies in tissue engineering. Cell Mol Med. 2007 Mar-Apr; 11(2):206-23.
  25. - Da´vila, Jose Luiz e d’A´vila Marcos Akira. Rheological evaluation of Laponite/alginate inks for 3D extrusion-based printing. © Springer-Verlag London Ltd., part of Springer Nature 2018
  26. - Stewart BW, Wild CP., eds (2014). World Cancer Report, IARC
  27. - Langer et al. (2019) Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting. CellPress, CellReport. Volume 26, Issue 3, 15 January 2019, Pages 608-623.e6.
  28. - Jaganathan, H., Gage, J., Leonard, F., Srinivasan, S., Souza, G.R., Dave, B., and Godin, B. (2014). Three-dimensional in vitro co-culture model of breast tumor using magnetic levitation. Sci. Rep. 4, 6468.Katt et al., 2016
  29. - Katt, M.E., Placone, A.L., Wong, A.D., Xu, Z.S., and Searson, P.C. (2016).In vitro tumor models: advantages, disadvantages, variables, and selectingthe right platform. Front. Bioeng. Biotechnol.4,12
  30. - Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.R., Rehnmark, S., Verbeke,C., Toftga° rd, R., Lo¨ hr, M., and Heuchel, R.L. (2013). 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a bettermodel for drug testing. BMC Cancer 13, 95.
  31. - Park, J., Morley, T.S., Kim, M., Clegg, D.J., and Scherer, P.E. (2014). Obesityand cancer–mechanisms underlying tumour progression and recurrence. Nat. Rev. Endocrinol. 10, 455–465.
  32. - Fong, E.L., Harrington, D.A., Farach-Carson, M.C., and Yu, H. (2016). Heralding a new paradigm in 3D tumor modeling. Biomaterials 108, 197–213.
  33. - Stadler, M., Walter, S., Walzl, A., Kramer, N., Unger, C., Scherzer, M., Unterleuthner, D., Hengstschla¨ ger, M., Krupitza, G., and Dolznig, H. (2015). Increased complexity in carcinomas: analyzing and modeling the interaction of human cancer cells with their microenvironment. Semin. Cancer Biol. 35, 107–124.
  34. - Weigelt, B., Ghajar, C.M., and Bissell, M.J. (2014). The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv. Drug Deliv. Rev. 69–70, 42–51. (Grolman et al., 2017; 35- Zhang, Y. S., Duchamp, M., Oklu, R., Ellisen, L. W., Langer, R., & Khademhosseini, A. (2016). Bioprinting the cancer microenvironment. ACS biomaterials science & engineering, 2(10), 1710-1721.


Download data is not yet available.


Metrics Loading ...